News

Abaxx Exchange Partners with TradingView for Enhanced Futures Access

Abaxx Exchange Partners with TradingView for Enhanced Futures Access

Abaxx Exchange Integrates with TradingView

Abaxx Technologies Inc. (CBOE:ABXX)(OTCQX:ABXXF), a leading financial software and market infrastructure company, has recently announced an exciting development for its futures market. By integrating its data with TradingView, a popular platform used by millions of traders worldwide, Abaxx aims to enhance market accessibility and transparency.

Accessing Futures Markets on TradingView

TradingView is renowned for its user-friendly charting tools and vast community of traders and investors. This new integration makes the full range of Abaxx’s physically deliverable futures contracts available for charting and analysis, putting critical market data into the hands of over 100 million TradingView users.

The Impact of This Integration

According to Joe Raia, Chief Commercial Officer of Abaxx Exchange, bringing their data to TradingView represents a significant step toward providing transparent benchmarks within the marketplace. Raia emphasized how this move broadens access to their contracts, ultimately benefiting both new and experienced traders.

Strategic Growth in Futures Contracts

Since its debut in June 2024, Abaxx Exchange has successfully introduced ten new futures benchmark contracts spanning various sectors including energy, environmental products, and precious metals. The visibility gained through TradingView further integrates Abaxx's innovative products into the daily workflows of traders globally, supporting expanded participation and enhancing global price discovery.

Exploring Abaxx’s Advanced Contract Offerings

With this integration, users can easily track and analyze new energy and metals benchmarks alongside established global contracts. For instance, traders interested in following the LNG and gold markets will now find it easier to access relevant information through TradingView.

Navigating Abaxx Contracts on TradingView

For those eager to view Abaxx Exchange market data, they can navigate to TradingView, utilize the symbol search feature, and enter “ABAXX:” followed by the specific product code, such as “ABAXX:GKSZ2025” for Gold Singapore Futures set for December 2025. This user-friendly approach encourages active engagement with Abaxx’s market offerings.

About Abaxx Technologies and Its Vision

Abaxx Technologies is on a mission to create Smarter Markets—driving solutions to significant societal challenges through better tools and technology. By developing financial technologies that simplify communication and transactions, the company aims to play a pivotal role in transitioning towards a sustainable, electrified economy.

Commitment to a Low-Carbon Future

Abaxx Exchange is committed to overseeing crucial market infrastructure that supports the shift toward a low-carbon economy through the provision of centrally-clear, physically deliverable futures contracts. This strategic focus meets the commercial needs of today’s commodity markets while setting the stage for the next generation of global benchmarks.

Innovative Solutions in Physical Gold Trading

In addition to its futures exchange, Abaxx Spot offers a modern approach to physical gold trading. This innovative model incorporates a physically-backed gold pool in Singapore, enabling secure electronic transactions and supporting physical delivery for futures contracts. This co-located market environment enhances the efficiency of gold market operations.

Contacting Abaxx for More Information

For inquiries or further information about Abaxx Technologies, please contact Steve Fray, CFO at +1 647-490-1590. Additionally, for media and investor relations, reach out to the Abaxx Investor Relations Team at +1 246 271 0082 or via email at ir@abaxx.tech.

Frequently Asked Questions

1. What is the recent partnership between Abaxx and TradingView?

Abaxx has integrated its futures market data with TradingView to enhance access for over 100 million users globally.

2. How can traders access Abaxx contracts on TradingView?

Traders can search for Abaxx contracts by entering the prefix “ABAXX:” followed by the contract's product code in the TradingView symbol search.

3. What types of products does Abaxx Exchange offer?

Abaxx Exchange offers futures contracts across sectors like energy, environmental products, battery materials, and precious metals.

4. What is the vision of Abaxx Technologies?

Abaxx aims to create Smarter Markets by using advanced tools and technology to address significant challenges in today's economy.

5. How can I contact Abaxx Technologies for further information?

Contact Steve Fray, CFO at +1 647-490-1590, or the Investor Relations Team at +1 246 271 0082 or ir@abaxx.tech.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 5

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading

Top 5 Most Recently Viewed Articles

XPENG Delivers 39,107 Vehicles in August 2026

Updated Category News Views 11

Grit and Green in XPENG's Latest Numbers You'd think someone at XPENG's HQ popped the champagne today, given what they're reporting, but don't let the buzz fool you. August 2026 saw them deliver 39,107 vehicles. That's a nice 4% tick up year over year. But remember, we're talking a sector where anything short of double digits can feel like a whisper instead of a roar....

Continue Reading
Artivion Set to Announce Financial Results in February 2026

Updated Category News Views 90

Artivion to Announce Fourth Quarter Financial Results Artivion, Inc. (NYSE: AORT), a renowned company in the cardiac and vascular sector, has set a date for the release of its fourth quarter financial results for the year 2025. The main announcement will occur on the afternoon of the market closing on February 12, 2026. This release is highly anticipated within investor...

Continue Reading
FibroBiologics and Charles River Unite for Cell Therapy Advancements

Updated Category News Views 181

FibroBiologics Partners with Charles River for Innovative Therapies FibroBiologics, Inc. (Nasdaq: FBLG), a pioneering biotechnology company, has announced a groundbreaking collaboration with Charles River Laboratories, a renowned name in drug discovery and manufacturing. This partnership aims to develop and manufacture advanced fibroblast cell-based therapies intended to...

Continue Reading
Axsome Therapeutics Looks Ahead with Participations in Events

Updated Category News Views 128

Axsome Therapeutics: Engaging the Investment Community Axsome Therapeutics, Inc. (NASDAQ: AXSM), a pioneering biopharmaceutical enterprise focused on revolutionary treatments for central nervous system (CNS) disorders, has exciting plans ahead as it prepares to engage with investors at significant upcoming conferences. This engagement highlights the company's commitment...

Continue Reading
Palmstreet's Bold Moves in the $68B Live Shopping Boom

Updated Category News Views 9

Palmstreet Sets the Stage for Seller Success As the live shopping phenomenon in the U.S. rivals the busiest stock market scramble, Palmstreet is laying down some serious game-changing strategies. We're staring at a market expected to hit a staggering $68 billion in 2026, more than doubling its size from three years ago. Instead of riding the coattails of this lucrative...

Continue Reading